Supplement analysis backed by scientific evidence · PT

← All supplements
Limited evidenceWomen's health

D-Mannose

D-mannose looked promising in small open-label studies, but the largest and best-designed trial — nearly 600 women in primary care — found no benefit over placebo for preventing recurrent UTIs. It is very safe and very likely ineffective.

What the science says

  • Prevents recurrent UTIs in women Limited evidence

    A 2024 randomized clinical trial assigned 598 women with recurrent UTI to 2 g/day of D-mannose or placebo for 6 months and found no significant difference: about 51% of the D-mannose group had at least one further clinically suspected UTI versus 55.7% on placebo, an absolute difference of roughly 5 percentage points that did not reach significance. The authors concluded D-mannose should not be recommended for prophylaxis in primary care.

  • Earlier evidence supported it Limited evidence

    The 2022 Cochrane review found only 7 eligible studies in 719 participants and rated the certainty of evidence as very low, concluding that no firm conclusions could be drawn about benefit or harm. The frequently cited positive results came largely from unblinded or non-placebo-controlled trials — exactly the design weakness the later placebo-controlled trial corrected.

  • Blocks E. coli adhesion to the bladder wall Moderate evidence

    The mechanism is real: D-mannose is excreted largely unmetabolized in urine, where it saturates the FimH adhesin on type-1 pili of uropathogenic E. coli and prevents attachment to urothelial mannose residues. A plausible mechanism that fails to translate into clinical benefit is a common pattern, and this appears to be one of them.

Dosage & safety

Studied doseTrials used 2 g/day as a single dose, or 1.5-2 g twice daily in earlier open-label protocols, for up to 6 months. Since the best trial was negative at 2 g/day, there is no dose that can be recommended for prevention on current evidence.
SafetyOne of the safer supplements available — D-mannose is a simple sugar, largely excreted unchanged. The main side effects are dose-dependent loose stools and bloating. It has minimal effect on blood glucose at typical doses, but people with diabetes should still monitor when starting. There is a theoretical concern about osmotic load in advanced kidney disease. Avoid using it in place of antibiotics for a febrile UTI or suspected pyelonephritis. Not banned in sport and no known drug interactions.

Scientific references

Where to buy

NOW Foods, Certified Organic D-Mannose Pure Powder, 6 oz (170 g)

View on iHerb

Referral link — this site may earn a commission on purchases.

Related in Women's health